抗体工程:融合后
实现融合后过程的自动化,免除了为选择稳定和高产单细胞克隆所需的大量的人工作业和长时间处理流程。Biomek 融合后系统从验证单克隆性开始,整体提高了实验的连贯性和高通量工作,结合有限稀释和蛋白质定量以及数据驱动的 Hit-picking。
下面展示的系统是一个整合的 Biomek i7 液体处理工作站的示例,该工作站专门为有效的管理杂交瘤筛选融合后实验流程所配置。该系统配置可以根据您的特定工作流的要求进行修改,以适应其他分析方法或实验室应用。
及时从贝克曼库尔特生命科学专家那里获得您感兴趣的信息。
© 2000-2025 贝克曼库尔特国际贸易(上海)有限公司保留最终解释权
NOT ALL PRODUCTS ARE AVAILABLE IN ALL COUNTRIES.
PRODUCT AVAILABILITY AND REGULATORY STATUS DEPENDS ON COUNTRY REGISTRATION PER APPLICABLE REGULATIONS
The listed regulatory status for products correspond to one of the below:
IVD: In Vitro Diagnostic Products. These products are labeled "For In Vitro Diagnostic Use."
ASR: Analyte Specific Reagents. These reagents are labeled "Analyte Specific Reagents. Analytical and performance characteristics are not established."
CE: Products intended for in vitro diagnostic use and conforming to European Directive (98/79/EC). (Note: Devices may be CE marked to other directives than (98/79/EC)
RUO: Research Use Only. These products are labeled "For Research Use Only. Not for use in diagnostic procedures."
LUO: Laboratory Use Only. These products are labeled "For Laboratory Use Only."
No Regulatory Status: Non-Medical Device or non-regulated articles. Not for use in diagnostic or therapeutic procedures.
沪ICP备18036651号-1
沪公网安备 31010502004935号
互联网药品信息服务资格证书(沪)-非经营性-2020-0189
沪(浦)应急管危经许[2022]200234